Home / Articles / Features / Earth Talk / The rap on rBGH
Print this Article
Wednesday, May 2, 2007 02:33 pm

The rap on rBGH

Why the demand for a ban is growing

art4053
Several nations have banned rBGH, including all 25 European Union nations, Japan, Australia, New Zealand and Canada.
PHOTO COURTESY OF GETTY IMAGES
Untitled Document Why are some groups pressing to ban rBGH, the hormone given to cows that makes them produce more milk?

Cows naturally produce bovine somatotropin in their pituitary glands, and traces are secreted by the animals when they are milked. More popularly known as BGH, or bovine growth hormone, BST interacts with other hormones in cows’ bodies to control the amount of milk they produce. As a means of increasing milk production, scientists working for Monsanto spent years in the lab developing a genetically engineered synthetic version of the hormone called rBGH, or recombinant bovine growth hormone. Monsanto obtained approval to market rBGH (known by the trade name Posilac) from the U.S. Food and Drug Administration in 1993 and began offering it to interested farmers. Today, about a third of American dairy cows are injected with rBGH, which boosts milk production by about 10 percent.
But the use of rBGH is controversial because of potential health hazards to both cows and human beings. According to the Center for Food Safety (and supported by a 2003 study published in the Canadian Journal of Veterinary Research), cows treated with rBGH suffer a 50 percent greater incidence of lameness (leg and hoof problems), 25 percent more udder infections (mastitis), and serious reproductive problems, including infertility, cystic ovaries, fetal loss, and birth defects.
Such animal health issues can sometimes translate into human ones: Antibiotics used to fight infection can find their way into milk, affecting our disease resistance. Also, animals given rBGH produce more insulin-like growth factor-1. Studies, says the Organic Consumers Association, have linked high levels of IGF-1 in people who consume rBGH milk with breast, prostate, colon, and other cancers. This suggests that our natural defenses against early cancerous cells are blocked by IGF-1.
Controversy also surrounds the fact that there are no labeling requirements in the United States for rBGH. In February 2007, the OCA, along with the Cancer Prevention Coalition and the Family Farm Defenders, filed a joint petition asking the FDA to require cancer-risk warning labels on all U.S. milk produced with rBGH. They also asked the FDA to suspend rBGH approval because of “imminent hazard.” Analysts doubt the FDA will take the request seriously, despite not knowing what problems with rBGH might arise down the road.
Monsanto maintains that human beings digest so little of the hormone that it has no direct effect on our health. The World Health Organization, the FDA and numerous medical associations concur that milk from rBGH-treated cows is safe for human consumption. However, many remain wary and, as a result, several nations have banned rBGH, including all 25 European Union nations, Japan, Australia, New Zealand, and Canada. In the United States, despite lack of federal concern, consumer pressure has led many companies to discontinue the use of rBGH. In January 2007, Safeway announced that it would go rBGH-free at both its Portland, Ore., and Seattle plants. Others following suit include Starbucks, Ben and Jerry’s, and Chipotle Mexican Grills.
For more information: Center for Food Safety, www.centerforfoodsafety.org; Cancer Prevention Coalition, www.preventcancer.com; Organic Consumers Association, www.organicconsumers.org; Family Farm Defenders, www.familyfarmdefenders.org.
Send questions to Earth Talk, care of E/The Environmental Magazine, P.O. Box 5098, Westport, CT 06881 or e-mail earthtalk@emagazine.com.
Log in to use your Facebook account with
IllinoisTimes

Login With Facebook Account



Recent Activity on IllinoisTimes

Calendar

  • Thu
    20
  • Fri
    21
  • Sat
    22
  • Sun
    23
  • Mon
    24
  • Tue
    25
  • Wed
    26